Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Will GILD's Strong HIV Portfolio Reap Rewards in 2026?
09:16am, Friday, 19'th Dec 2025
GILD???s HIV franchise gains momentum as twice-yearly PrEP Yeztugo wins FDA approval and late-stage data back a new single-tablet regimen.
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
08:30am, Thursday, 18'th Dec 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General Counsel, Legal & Compliance effective
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
06:51pm, Wednesday, 17'th Dec 2025
Gilead Sciences (GILD) closed the most recent trading day at $121.36, moving +2.17% from the previous trading session.
GILD's Bictegravir and Lenacapavir Regimen for HIV Meets Primary Goal
09:56am, Tuesday, 16'th Dec 2025
Gilead said its once-daily bictegravir/lenacapavir tablet met non-inferiority vs Biktarvy in phase III ARTISTRY-2, paving the way for filings.
3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains
10:10am, Monday, 15'th Dec 2025
Inflation, interest rates, and broader economic uncertainty have forced companies across many sectors to prioritize efficiency. In this environment, it can be particularly challenging for firms to mai
Gilead's experimental HIV treatment meets main goal in late-stage trial
08:43am, Monday, 15'th Dec 2025
Gilead Sciences said on Monday its experimental HIV treatment met the main goal in a late-stage trial.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment re
Ameriprise Financial Inc. Boosts Holdings in Gilead Sciences, Inc. $GILD
05:52am, Saturday, 13'th Dec 2025
Ameriprise Financial Inc. grew its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 397.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Ex
AQR Capital Management LLC Has $272.21 Million Stake in Gilead Sciences, Inc. $GILD
05:52am, Saturday, 13'th Dec 2025
AQR Capital Management LLC increased its position in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 32.5% in the undefined quarter, according to the company in its most recent filing with the Secur
Investors Buy Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD)
01:14am, Saturday, 13'th Dec 2025
Gilead Sciences, Inc. (NASDAQ: GILD - Get Free Report) was the target of some unusual options trading on Friday. Stock investors acquired 165,669 call options on the company. This is an increase of 1,
Gilead, Arcus scrap late-stage trial of cancer drug combo
08:36am, Friday, 12'th Dec 2025
Gilead Sciences and Arcus Biosciences said on Friday they would stop a late-stage study testing their experimental cancer drug combination in patients with advanced stomach and esophageal cancers afte
Here's Why Gilead Sciences (GILD) is a Strong Value Stock
10:40am, Thursday, 11'th Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ariel Investments LLC Has $40.90 Million Position in Gilead Sciences, Inc. $GILD
03:31am, Wednesday, 10'th Dec 2025
Ariel Investments LLC lessened its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 14.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. Th
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
08:30am, Tuesday, 09'th Dec 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Foundation awards $3M in grants to close gaps in education, care, and support for people living with metastatic breast cancer.
SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consiste
